Join
Live feed
·
PRReleasevia Quantisnow
Capstar Special Purpose Acquisition Corp. logo
Gelesis Holdings Inc. logo
PureTech Health plc logo

PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022

ByQuantisnow·Wall Street's wire, on your screen.
CPSR· Capstar Special Purpose Acquisition Corp.GLS· Gelesis Holdings Inc.PRTC· PureTech Health plc
FinanceHealth Care
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022 | Quantisnow